The future prospects of endostatin in cancer treatment are promising. Advances in biotechnology and drug delivery systems may enhance its stability and bioavailability, making it more effective in clinical settings. Furthermore, personalized medicine approaches, which tailor treatments to individual patient profiles, could maximize the therapeutic benefits of endostatin. Continued research and innovation are essential to fully harness its potential in combating cancer.
